Corteva competitor Inari must face seed patent lawsuit
By Blake Brittain
Aug 5 (Reuters) -Agriculture technology giant Corteva Agriscience CTVA.N can move forward with its lawsuit accusing startup Inari Agriculture of unlawfully copying its patented seeds, according to a ruling made public in Delaware federal court on Monday.
U.S. District Judge John Murphy refused to dismiss the lawsuit, finding that Inari failed to prove at an early stage of the case that its Belgian subsidiary could develop its own genetically modified plants from Corteva's seeds without violating U.S. intellectual property laws.
Spokespeople for Inari did not immediately respond to a request for comment on the decision. A spokesperson for Corteva declined to comment.
Delaware-based Corteva spun off from DowDuPont DOW.N in 2019. It sued Cambridge, Massachusetts-based Inari last year, alleging that the competing startup obtained Corteva's protected seed samples from a nonprofit and transferred the seeds to its Belgian branch to exploit them, violating a Corteva patent and other intellectual property rights.
In its dismissal bid, Inari had argued that the nonprofit that provided the seed samples "authorizes unrestricted availability to the public of those seeds" regardless of Corteva's rights. Inari also said that U.S. patent law does not apply to its use of the seeds in Belgium and that its testing of them could not be an infringing act.
Murphy said Inari's arguments relied on assumptions that it still needed to prove.
"Many of Inari's arguments require the assumption that whatever Inari is accused of doing is nothing more than what any member of the public is entitled to do with a deposited seed," Murphy said. "An interesting notion, but is it true?"
The case is Corteva Agriscience LLC v. Inari Agriculture Inc, U.S. District Court for the District of Delaware, No. 1:23-cv-01059.
For Corteva: Peter Bicks, David Gindler, Lauren Drake and Gary Frischling of Orrick Herrington & Sutcliffe; Todd Vare, Ronald Cahill and Chad Stover of Barnes & Thornburg
For Inari: Dimitrios Drivas, Raj Gandesha and John Scheibeler of White & Case; Robert Isackson of Leason Ellis
Reporting by Blake Brittain in Washington
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
